Search

Your search keyword '"Valera-Rubio M"' showing total 26 results
Start Over Author "Valera-Rubio M"
26 results on '"Valera-Rubio M"'

15. Nationwide current situation of hospital pharmacists in intensive care units

Author

Valera-Rubio M, Domingo-Chiva E, Aquerreta-González I, Periáñez-Párraga L, Ruiz-Ramos J, and Soy-Muner D

Subjects
Critical care, Hospital pharmacist, education, Intensive care unit
Abstract

To describe the current situation of the hospital pharmacistin intensive care units and their activity in care, in teaching and inresearch.

Published
2019

22. Guía de Terapéutica Antimicrobiana del Área Aljarafe, 3ª edición

Author

Acosta García, Héctor, Aibar Remón, Carlos, Alcázar, Francisco Javier, Alonso, Maria Teresa, Alvarado Fernández, Dolores, Anaya Ordóñez, Sonia, Anguis, Juan Ignacio, Aspíroz Sancho, Carmen, Aznar Martín, Javier, Beltrán Calvo, Carmen, Benavente, Regina Sandra, Bernabeu Wittel, José, Bravo Escudero, Carmen, Campa, Azucena de la, Campo Gracia, Angel del, Campos, Juan Miguel, Cansino Romero, Francisco Javier, Carlos Gil, Ana M., Cantudo Cuenca, M. Dolores, Catalán, José Manuel, Chavez Caballero, Mónica, Corbi Llopis, Rosa, Corral Baena, Susana, Cots, Josep María, Cruces Jiménez, José Miguel, Cruz Navarro, Natalio, Cuétara, Marisol, Cueto, Marina de, Delgado de la Cuesta, Juan, Domínguez Cruz, Javier, Domínguez Jiménez, Mª Carmen, Espín, Beatriz, Espinosa Calleja, Ricardo, Expósito García, Sebastián, Fernández Moyano, Antonio, Fernández Urrusuno, Rocío, Flores Dorado, Macarena, Franco Alvarez de Luna, Francisco, Franco Márquez, M. Luisa, Galván Banqueri, Mercedes, Garabito Sánchez, M. José, García Estepa, Raúl, García Jiménez, Emilio, García López, José Luis, García Moreno, Mercedes, García Sánchez, Cristina, García de la Vega Sosa, Manuel, Garrido Arce, Macarena, Gilaberte Calzada, Yolanda, Huguet, Montse, Jiménez Pavón, Maria Luisa, Giménez Júlvez, Teresa, Gómez Gómez, Maria José, Gómez Vázquez, Ana, Guerrero Casas, Aurora, Hernández, Francisco Javier, Jiménez Vizcaino, Beatriz, Laureano Zarza, Miguel, Lepe Jiménez, José Antonio, Llor, Carles, López Cerero, Lorena, Manzano, M. Carmen, Marmesat, Francisco, Martín Grutmancher, Fernando, Martín Márquez, Fátima, Martínez Granero, Mercedes, Martínez-Gil Pardo de Vera, Cristina, Martínez Roda, M. José, Mata Martín, Ana, Merino de la Torre, Esther, Millán Cantero, Helena, Molina Linde, Juan Máximo, Montero Balosa, M. Carmen, Montes Sánchez, María del Carmen, Muñoz Yribarren, Cristina, Olivencia Pérez, Miguel, Palacios Baena, Zaira R., Olmedo Rivas, Cinta, Palma Morgado, Daniel, Pascual Hernández, Álvaro, Pascual de la Pisa, Beatriz, Pereira Delgado, Consuelo M., Pérez Pérez, Pastora, Pérez Santos, M. Jesús, Periáñez Párraga, Leonor, Pinilla Cordero, Sonia, Poyato, Manuel, Praena Segovia, Julia, Ramírez Arcos, Mercedes, Reinosa Santiago, Alfredo, Retamar Gentil, Pilar, Rigueira, Ana, Robustillo Cortés, M. de las Aguas, Rodríguez Baño, Jesús, Rodríguez Benjumeda, Luis Miguel, Rodríguez Pappalardo, Vicente, Roldán Valenzuela, Andrés, Romero García, Ana, Rosario Lozano, M. Piedad, Ruiz Pérez de Pipaón, Maite, Sabalete Moya, Trinidad, Sánchez Fernández, Norma, Sánchez Moreno, María, Santos Lozano, José Manuel, Serrano Martino, Carmen, Solís de Dios, Miguel, Suárez Barrenechea, Anabel, Taboada Prieto, Salomé, Toro López, M. Dolores, Trueba Lawand, Araceli, Valera Rubio, Marta, Vázquez Florido, Antonio, Yanes Martín, Jaime, [Acosta García,H, Carlos Gil,AM, Galván Banqueri,M, García Estepa,R,Molina Linde,JM, Robustillo Cortés,MA, Rosario Lozano,MP, Sabalete Moya,T, Valera Rubio,M] Agencia de Evaluación de Tecnologías Sanitarias de Andalucía. [Aibar Remón,C] Departamento de Microbiología, Medicina Preventiva y Salud Pública. Universidad de Zaragoza. Servicio de Medicina Preventiva y Salud Pública. Hospital Clínico Universitario Lozano Blesa. Zaragoza. [Alcázar,FJ,Campa,A, Campo Gracia,A, Cantudo Cuenca,MD, Catalán,JM, Chavez Caballero,M, Corral Baena,S, Delgado de la Cuesta,J, Espinosa Calleja,R, Expósito García,S, Fernández Moyano,A, Franco Márquez,ML, Garabito Sánchez,MJ, Garrido Arce,M, Gómez Vázquez,A, Hernández,FJ, Martín Márquez,F, Martínez Roda,MJ, Mata Martín,A,Merino de la Torre,E, Millán Cantero,H, Muñoz Yribarren,C, Olivencia Pérez,M, Olmedo Rivas,C, Pereira Delgado,CM, Poyato,M, Ramírez Arcos,M, Serrano Martino,C, Taboada Prieto,S, Trueba Lawand,A] Hospital San Juan de Dios del Aljarafe, Bormujos, Sevilla. [Alonso,MT, Aznar Martín,J, Bernabeu Wittel,J, Corbi Llopis,R, Cruz Navarro,N, Domínguez Cruz,J, Espín,B, García Sánchez,C, Gómez Gómez,MJ, Lepe Jiménez,JA, Praena Segovia,J, Ruiz Pérez de Pipaón,M, Vázquez Florido,A] Hospital Universitario Virgen del Rocío, Sevilla. [Alvarado Fernández,D, Cueto,M, López Cerero,L, Palacios Baena,ZR, Pascual Hernández,A, Retamar Gentil,P, Rodríguez Baño,J, Toro López,MD] Hospital Universitario Virgen Macarena, Sevilla. [Anaya Ordóñez,S] UGC Farmacia Granada Intercentros. [Anguis,JI, Beltrán Calvo,C, Bravo Escudero,C, Campos,JM, Cruces Jiménez,JM, Fernández Urrusuno,R, García de la Vega Sosa,M, Jiménez Pavón,ML, Guerrero Casas,A, Jiménez Vizcaino,B, Laureano Zarza,M, Marmesat,F, Martínez Granero,M, Montero Balosa,MC, Montes Sánchez,MC, Pascual de la Pisa,B, Pinilla Cordero,S, Reinosa Santiago,A, Rodríguez Benjumeda,LM, Rodríguez Pappalardo,V, Roldán Valenzuela,A, Romero García,A, Sánchez Fernández,N, Solís de Dios,M, Yanes Martín,J] Distrito Sanitario Aljarafe-Sevilla Norte, Servicio Andaluz de Salud, Sevilla. [Aspíroz Sancho,C] Hospital Royo Villanova, Zaragoza. [Benavente,RS, Domínguez Jiménez,MC] Área de Gestión Sanitaria de Osuna, Sevilla. [Cansino Romero,FJ] Residencia Geriátrica Montetabor. Bollullos de la Mitación, Sevilla. [Cuétara,M] Servicio de Microbiología del Hospital Severo Ochoa de Leganés, Madrid. [Flores Dorado,M] Área de Gestión Sanitaria Norte de Cádiz, Cádiz. [Franco Alvarez de Luna,F] Hospital de Ríotinto, Huelva. [García López,JL, Suárez Barrenechea,A] Servicio de Microbiología, Hospital Virgen de Valme, Sevilla. [García Moreno,M] Residencia de Mayores de la Junta de Andalucía Huerta Palacio. Dos Hermanas, Sevilla. [Gilaberte Calzada,Y, Giménez Júlvez,T] Hospital Miguel Servet, Zaragoza. [Huguet,M] Residencia CER Espartinas, Espartinas, Sevilla. [Martínez-Gil Pardo de Vera,C] Area de Gestión Sanitaria Norte de Jaén, Jaén. [Palma Morgado,D, and Santos Lozano,JM] Distrito Sevilla, Sevilla. [Pérez Pérez,P] Observatorio para la Seguridad del Paciente. Agencia de Calidad Sanitaria de Andalucía. Sevilla. [Pérez Santos,MJ] Servicio Microbiología. Hospital de Ronda. Málaga. [Periáñez Párraga,L] Hospital Son Espases, Palma Mallorca. [Regueira,A] Hospital San Agustín, Avilés, Asturias. [Sánchez Moreno,M] Area de Gestión Sanitaria Sur de Sevilla, Sevilla.

Subjects
Uso de la información científica en la toma de decisiones en salud, Administración del Tratamiento Farmacológico, Usos terapéuticos, Toma de decisiones clínicas, Terapéutica, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics [Medical Subject Headings], Guía de tratamiento antimicrobiano, Andalucía, Health Care::Health Services Administration::Organization and Administration::Decision Making, Organizational [Medical Subject Headings], Publication Type::Publication Formats::Guideline::Practice Guideline [Medical Subject Headings], Guía de práctica clínica, Health Care::Health Care Facilities, Manpower, and Services::Health Services::Pharmaceutical Services::Medication Therapy Management [Medical Subject Headings], Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents [Medical Subject Headings], Antiinfecciosos, Antimicrobianos, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses [Medical Subject Headings]
Abstract

Coordinadora: Rocío Fernández Urrusuno. Co-coordinadora: Carmen Serrano Martino. Estas guías son un recurso indispensable en los Programas de Optimización de Antibióticos (PROA). No sólo constituyen una herramienta de ayuda para la toma de decisiones en los principales síndromes infecciosos, proporcionando recomendaciones para el abordaje empírico de dichos procesos, sino que son el patrón/estándar de referencia que permitirá determinar la calidad o adecuación de los tratamientos realizados. Las guías pueden ser utilizadas, además, como herramienta de base para la formación y actualización en antibioterapia, ya que permiten mantener actualizados los conocimientos sobre las nuevas evidencias en el abordaje de las infecciones. Por último, deberían incorporar herramientas que faciliten el proceso de toma de decisiones compartidas con el paciente. El objetivo de esta guía es proporcionar recomendaciones para el abordaje de las enfermedades infecciosas más prevalentes en la comunidad, basadas en las últimas evidencias disponibles y los datos de resistencias de los principales patógenos que contribuyan a mejorar la calidad de la prescripción de antimicrobianos. Yes

Published
2018

23. [Translated article] Activities of clinical pharmacists in intensive care units.

Author

Becerril-Moreno F, Valera-Rubio M, Aquerreta-González I, Domingo-Chiva E, Doménech-Moral L, Martín-Cerezuela M, de Gamarra-Martínez EF, and Cobo-Sacristán S

Abstract

The main objective of the activity carried out in an intensive care unit (ICU) and in general, in all hospitalization units, is to provide all the human and material resources to offer the best therapeutic care to admitted patients. Work in multidisciplinary teams, made up of specialists in intensive care medicine as those responsible for the patients, doctors from other specialties, specialized nursing, physiotherapists, nutritionists, and clinical pharmacists is an optimal approach to achieve the proposed objective. The activities of the clinical pharmacist can be developed at different levels (basic, intermediate, and excellent) depending on the degree of involvement, the time dedicated, the training, and the available resources. This article aims to establish an initial work guide, through recommendations aimed at the activity to be developed by the clinical pharmacist in the ICU in relation to critical patient care and quality improvement, which serves as a reference for those pharmacists who go to develop pharmaceutical care activities in critical patients., Competing Interests: Declaration of competing interest None declared., (Copyright © 2024. Publicado por Elsevier España, S.L.U.)

Published
2025
Full Text
View/download PDF

24. Activities of the clinical pharmacist in the intensive care units.

Author

Becerril-Moreno F, Valera-Rubio M, Aquerreta-González I, Domingo-Chiva E, Doménech-Moral L, Martín-Cerezuela M, Fernández de Gamarra-Martínez E, and Cobo-Sacristán S

Abstract

The main objective of the activity carried out in an intensive care unit and in general in all hospitalization units, is to provide all the human and material resources to offer the best therapeutic care to admitted patients. Work in multidisciplinary teams, made up of specialists in Intensive Care Medicine as those responsible for the patients, doctors from other specialties, specialized nursing, physiotherapists, nutritionists and clinical pharmacists is an optimal approach to achieve the proposed objective. The activities of the clinical pharmacist can be developed at different levels (basic, intermediate and excellent) depending on the degree of involvement, the time dedicated, the training and the available resources. This article aims to establish an initial work guide, through recommendations aimed at the activity to be developed by the clinical pharmacist in the ICU in relation to critical patient care and quality improvement, which serves as a reference for those pharmacists who go to develop pharmaceutical care activities in critical patients., (Copyright © 2024. Publicado por Elsevier España, S.L.U.)

Published
2024
Full Text
View/download PDF

25. Correction to: Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety.

Author

Manrique-Rodríguez S, Heras-Hidalgo I, Pernia-López MS, Herranz-Alonso A, Del Río Pisabarro MC, Suárez-Mier MB, Cubero-Pérez MA, Viera-Rodríguez V, Cortés-Rey N, Lafuente-Cabrero E, Martínez-Ortega MC, Bermejo-López E, Díez-Sáenz C, López-Sánchez P, Gaspar-Carreño ML, Achau-Muñoz R, Márquez-Peiró JF, Valera-Rubio M, Domingo-Chiva E, Aquerreta-González I, Ariño IP, Martín-Delgado MC, Herrera-Gutiérrez M, Gordo-Vidal F, Rascado-Sedes P, García-Prieto E, Fernández-Sánchez LJ, Fox-Carpentieri S, Lamela-Piteira C, Guerra-Sánchez L, Jiménez-Aguado M, and Sanjurjo-Sáez M

Published
2021
Full Text
View/download PDF

26. Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety.

Author

Manrique-Rodríguez S, Heras-Hidalgo I, Pernia-López MS, Herranz-Alonso A, Del Río Pisabarro MC, Suárez-Mier MB, Cubero-Pérez MA, Viera-Rodríguez V, Cortés-Rey N, Lafuente-Cabrero E, Martínez-Ortega MC, Bermejo-López E, Díez-Sáenz C, López-Sánchez P, Gaspar-Carreño ML, Achau-Muñoz R, Márquez-Peiró JF, Valera-Rubio M, Domingo-Chiva E, Aquerreta-González I, Ariño IP, Martín-Delgado MC, Herrera-Gutiérrez M, Gordo-Vidal F, Rascado-Sedes P, García-Prieto E, Fernández-Sánchez LJ, Fox-Carpentieri S, Lamela-Piteira C, Guerra-Sánchez L, Jiménez-Aguado M, and Sanjurjo-Sáez M

Subjects
Adult, Algorithms, Delphi Technique, Humans, Hydrogen-Ion Concentration, Inpatients, Irritants, Osmolar Concentration, Phlebitis etiology, Spain, Vascular Access Devices adverse effects, Vascular Access Devices standards, Infusions, Intravenous adverse effects, Infusions, Intravenous standards
Abstract

Background: Intravenous drug administration is associated with potential complications, such as phlebitis. The physiochemical characteristics of the infusate play a very important role in some of these problems., Aim: The aim of this study was to standardize the dilutions of intravenous drugs most commonly used in hospitalized adult patients and to characterize their pH, osmolarity and cytotoxic nature to better guide the selection of the most appropriate vascular access., Methods: The project was conducted in three phases: (i) standardization of intravenous therapy, which was conducted using a modified double-round Delphi method; (ii) characterization of the dilutions agreed on in the previous phase by means of determining the osmolarity and pH of each of the agreed concentrations, and recording the vesicant nature based on the information in literature; and (iii) algorithm proposal for selecting the most appropriate vascular access, taking into account the information gathered in the previous phases., Results: In total, 112 drugs were standardized and 307 different admixtures were assessed for pH, osmolarity and vesicant nature. Of these, 123 admixtures (40%), had osmolarity values >600 mOsm/L, pH < 4 or > 9, or were classified as vesicants. In these cases, selection of the most suitable route of infusion and vascular access device is crucial to minimize the risk of phlebitis-type complications., Conclusions: Increasing safety of intravenous therapy should be a priority in the healthcare settings. Knowing the characteristics of drugs to assess the risk involved in their administration related to their physicochemical nature may be useful to guide decision making regarding the most appropriate vascular access and devices.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results